Vineet Laboratories Limited (BOM:543298)

Market Cap	590.98M +27.6%
Revenue (ttm)	560.13M -48.5%
Net Income	-101.39M
EPS	-11.04
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	537
Average Volume	4,580
Open	30.77
Previous Close	30.65
Day's Range	30.24 - 31.10
52-Week Range	25.35 - 51.84
Beta	n/a
RSI	40.01
Earnings Date	Jan 22, 2026

About Vineet Laboratories

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl th...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2016
• Employees: 57
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543298